| JXSL1500056 | Blinatumomab | blinatumomab | Lyophilized | Biological Products | Import Drug Application | 2015-09-17 | Amgen Inc. | Amgen Inc | Certificate Issued | 2016-09-29 | view |
| JXSS1900060 | 注射用倍林妥莫双抗 | blinatumomab | Lyophilized | Biological Products | Import Drug Application | 2019-10-29 | 安进生物技术咨询（上海）有限公司 | Amgen Biology Technology Consulting (Shanghai) Co Ltd;Amgen Inc;Boehringer Ingelheim Pharma Gmbh & Co KG | Certificate Issued | 2020-12-08 | view |
| JYSB2200192 | 注射用贝林妥欧单抗 | blinatumomab | Lyophilized | Biological Products | Supplementary Application | 2022-10-11 | | Amgen Inc;Amgen Technology (Ireland) UnLtd Company | | | view |
| JYSB2500031 | 注射用贝林妥欧单抗 | blinatumomab | Lyophilized | Biological Products | Supplementary Application | 2025-02-12 | | Amgen Inc;Amgen Technology (Ireland) UnLtd Company | | | view |
| JXSS2100020 | 注射用贝林妥欧单抗 | blinatumomab | Lyophilized | Biological Products(3.1) | Import Drug Application | 2021-03-31 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd;Amgen Inc;Amgen Technology (Ireland) UnLtd Company | In Review | 2021-03-30 | view |
| JYSB2100061 | 注射用贝林妥欧单抗 | blinatumomab | Lyophilized | Biological Products(3.1) | Supplementary Application | 2021-02-26 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd;Amgen Inc;Amgen Technology (Ireland) UnLtd Company | In Review | 2022-01-27 | view |
| JYSZ2400059 | 注射用贝林妥欧单抗 | blinatumomab | Lyophilized | Biological Products | License Renew | 2024-12-10 | | Amgen Inc;BeiGene (Beijing) Co Ltd;Amgen Technology (Ireland) UnLtd Company | | | view |
| JYSB2300008 | 注射用贝林妥欧单抗 | blinatumomab | Lyophilized | Biological Products | Supplementary Application | 2023-01-14 | | Amgen Inc;Amgen Technology (Ireland) UnLtd Company | | | view |
